Genpact Limited (G) AI Stock Analysis

Genpact Limited provides business process outsourcing and information technology services across India, Asia, North and Latin America, and Europe. It operates across three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company offers CFO advisory, ESG solutions, supply chain advisory, sourcing, procurement, and commercial services. It is recognized for finance and accounting functions such as accounts payable, invoice-to-cash, and record-to-report services. Additionally, Genpact provides IT infrastructure management, application support, database management, and digital analytics services to enhance operational efficiency.

Between FY2021 and FY2025, Genpact expanded annual revenue from $4.02B to $5.08B, delivering a 5-year revenue CAGR of 6.5%. Operating margin improved from 12.7% in FY2021 to 15.0% in FY2025, while gross margin remained stable at 35.6%. Net income reached $552.5M in FY2025, with diluted EPS of $3.54. Over the trailing twelve months, revenue totaled $5.25B with a 15.0% operating margin and an 11.1% profit margin. In the latest quarter ended June 30, 2026, Genpact posted year-over-year quarterly revenue growth of 7.1% and earnings growth of 14.7%.

As of June 30, 2026, Genpact held $517.4M in cash and short-term investments against total debt of $1.41B, resulting in net debt of $897.2M. The company reported shareholders' equity of $2.60B, total assets of $5.41B, a debt-to-equity ratio of 0.54, and a current ratio of 2.00. In FY2025, operating cash flow was $812.9M, funding $78.2M in capital expenditures. Cash returns to shareholders included $283.0M in share buybacks and $117.7M in dividends, contributing to an 11.8% reduction in share count over 5 years.

Genpact trades at a trailing P/E of 11.1x and an EV to EBITDA of 7.0x, compared to medians of 28.1x and 16.6x, respectively, for its US-listed Technology peers. Its forward P/E of 18.3x sits below the peer median of 18.8x, while its price-to-sales multiple is 1.2x versus 2.8x for the peer group. Over the past year, the stock fell 2.4%, while the S&P 500 gained 16.8%. Over a 5-year span, the stock fell 19.4% compared to an 83.0% rise for the S&P 500.

Genpact pays an annual forward dividend of $0.75 per share, representing a 2.01% dividend yield. The payout ratio is 19.3%, with payments distributed on a quarterly frequency. The company has paid dividends for 10 consecutive years, recording a 5-year annualized dividend growth rate of 11.6%. Its last ex-dividend date was September 10, 2026.

Wall Street coverage includes 4 Strong Buy, 1 Buy, and 7 Hold ratings. The mean price target is $42.64, representing a 14.4% premium over the last close of $37.26. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $5.44B and EPS of $4.12, reflecting 12.9% EPS growth. Genpact has beaten EPS estimates in each of the last 4 quarters, with its next earnings date scheduled for November 5, 2026.

This page is an AI-written research summary of Genpact Limited (G). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: G income statement, G balance sheet, G key metrics, G analyst forecast, G chart. See the G stock overview for the latest quote and news.